The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer's disease.
Ando K, Ndjim M, Turbant S, Fontaine G, Pregoni G, Dauphinot L, Yilmaz Z, Suain V, Mansour S, Authelet M, et al. Acta Neuropathol Commun. 2020 Jun 3; 8(1):79. Epub 2020 Jun 3.